Other
NPC
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
NPC is an early-stage landscape with 0 programs across 1 company. The most active players are Nobelpharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Completed7 · 58%
Recruiting2 · 17%
Terminated1 · 8%
Available1 · 8%
Unknown status1 · 8%
Clinical Trials
Trial Activity
12 trials
Optimization of Cervical Nodal CTV for Early and Medium Stage NPC
Recruiting·—·Phase 3·NCT05145660·414 enrolled
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
Completed·—·Phase 1·NCT00516087·23 enrolled
NPC - AXEL Study : Axitinib-Avelumab
Completed·—·Phase 2·NCT04562441·13 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)